Scott Armstrong Scott Armstrong

Democrats Won Both Chambers. The Congressional Subpoenas Start in January.

Democrats won the House and Senate on November 3, 2026, and incoming committee chairs answered within hours: “LAWYER UP” and “Subpoenas.” Former DOJ prosecutors Scott Armstrong and Drew Bradylyons, a Chambers-ranked white-collar and government investigations firm in Washington, D.C., explain what the incoming chairs have said on the record, how a Democratic Senate changes subpoena enforcement, which crypto, prediction market, and donor investigations will move first, and how a congressional record becomes a DOJ, SEC, CFTC, or state case.

Read More
Scott Armstrong Scott Armstrong

The War on Fraud Comes to Behavioral Health

In ten days in October 2026, DOJ launched a $25 million whistleblower bounty, opened a False Claims Act self-disclosure pilot, indicted a Virginia crisis-services owner on $49 million in alleged false claims, and raided two Minnesota autism centers. Former DOJ Fraud Section prosecutors explain how the cases were built and what owners, clinicians, and billers face now.

Read More
Scott Armstrong Scott Armstrong

CMS Exclusion Authority Without a Conviction: 2026 Delegation

On October 14, 2026, HHS delegated Section 1128(b) permissive exclusion authority to the CMS Administrator. CMS can now exclude providers from every federal health care program on claims data alone, with no conviction and no referral to OIG. Former DOJ Fraud Section prosecutors explain the grounds, the 30-day notice of intent response, the ALJ appeal, reinstatement, and four defense points the early commentary has missed.

Read More
Scott Armstrong Scott Armstrong

Crypto Asset Freezes, Website Seizures, and Forfeiture: Inside DOJ’s October 2026 Enforcement Push and Where the Defense Begins

In two days in October 2026, DOJ, the FBI, and the Brooklyn District Attorney identified more than $11 million in freezable crypto, seized 241 scam domains and 112 servers, and took 187 devices from North Korean laptop farms. Former DOJ prosecutors Scott Armstrong and Drew Bradylyons explain how exchange freezes, seizure warrants, and forfeiture deadlines work, who is exposed, and where the defense begins.

Read More
Scott Armstrong Scott Armstrong

Cherry-Picking Cases: SEC, CFTC, DOJ Enforcement and Defense

Two cherry-picking cases were filed in the past four weeks, following a 2024 indictment of a chief investment officer and a 2023 criminal case against a commodity pool operator trading crypto futures. Former DOJ Fraud Section supervisors analyze what the SEC, CFTC, and DOJ plead in every case, the charges each agency brings, how the cases reach securities, futures, and crypto, and how the data, the documents, and the cooperating witnesses are contested at trial.

Read More
Scott Armstrong Scott Armstrong

Congressional Crypto Investigations After the 2026 Midterms: Subpoenas, Insider Trading, and Defense

Democrats say Trump-linked crypto ventures, including World Liberty Financial and 1789 Capital, will be early targets if they win the House or Senate in November 2026. Former DOJ fraud prosecutors explain which committees would investigate, how subpoenas, depositions, and referrals work, why insider trading and market manipulation are the likeliest criminal theories, and which defenses executives, companies, and witnesses can use.

Read More
Scott Armstrong Scott Armstrong

Empower Pharmacy FDA Warning Letter: What It Means for Other Pharmacies, Prescribers, Clinics, and Labs

FDA's September 2026 warning letter to Empower Pharmacy finds its compounded tirzepatide and semaglutide products are essentially copies of approved GLP-1 drugs and flags prescriber statements repeated verbatim across many records. Former DOJ prosecutors explain the seizure, injunction, criminal, and kickback exposure for compounders, telehealth platforms, prescribers, med spas, and executives.

Read More
Scott Armstrong Scott Armstrong

CFTC Cash FX Complaint: AI-Washing and a $950M Forex Ponzi

On September 24, 2026, the CFTC sued Cash FX Group, its CEO, a U.S. software vendor, and a Florida promoter, alleging a $950 million MLM Ponzi scheme marketed as AI-driven forex trading. Former DOJ fraud prosecutors analyze the fraud counts, the complaint's untested allegations, AI-washing enforcement at the CFTC and SEC, and the defenses available to each defendant.

Read More
Scott Armstrong Scott Armstrong

Robinhood, Hyperliquid, and Commodities Fraud: Inside the SDNY Insider Trading Complaints

SDNY charged two former Robinhood engineers with commodities fraud and wire fraud for trading Hyperliquid perpetual futures ahead of crypto listing announcements. Former DOJ Fraud Section prosecutors break down the charging theory, the Chastain property problem, the commodity and swap classification questions, and the attribution gaps in the affidavits.
Read More
Scott Armstrong Scott Armstrong

Farmmi, Memecoins, and the Crypto Market Manipulation Gap

A memecoin paired with an unofficial FAMI token preceded a 350% surge in a Nasdaq microcap. Former DOJ prosecutors Scott Armstrong and Drew Bradylyons analyze the wash trading and spoofing statutes, the regulatory gap for spot crypto, and why market manipulation enforcement is poised to return.

Read More
Scott Armstrong Scott Armstrong

Crypto AI Fraud Defense: DOJ and SEC Target Fake Trading Algorithms

On August 24, 2026, federal juries in Nevada and California convicted two crypto founders of fraud built on fake AI and trading algorithm claims. The verdicts mark the enforcement theme the SEC and DOJ have named a priority, and they show how these document-heavy cases are fought at trial on falsity, materiality, and intent to defraud.

Read More
Scott Armstrong Scott Armstrong

Compounded Semaglutide FDA Warning Letters: Criminal & FCA Risk

FDA announced 30 warning letters to telehealth companies over compounded semaglutide and tirzepatide marketing on March 3, 2026, then issued 25 more on June 8. One day later, DOJ unsealed a counterfeit Ozempic indictment. Former DOJ Fraud Section prosecutors explain how warning letters become criminal evidence, why False Claims Act and Anti-Kickback cases against compounders and telehealth prescribers are the next phase, and where the defense begins.

Read More
Scott Armstrong Scott Armstrong

FDA Warning Letter to R3 Medical Companies (August 2026): Stem Cell and Exosome Enforcement, CGMP Charges, and Criminal Exposure

FDA posted its August 2026 stem cell warning letter to R3 Medical Companies, the enterprise behind R3 Stem Cell and the ReBella product line. Built from facility inspections rather than a website review, the letter charges unapproved drug, unlicensed biologic, and CGMP adulteration violations, cites the company's own social media as evidence, and recites seven years of FDA notice to the same CEO. Former DOJ prosecutors break down what it means for the regenerative medicine industry.

Read More
Scott Armstrong Scott Armstrong

FDA Ketamine Warning Letters: Criminal and Civil Exposure for Ketamine Clinics, Prescribers, and Online Sellers

FDA issued more than a dozen warning letters to online ketamine sellers on June 23, 2026, citing unapproved new drug and misbranding violations. Former DOJ prosecutors explain the criminal exposure under the FDCA and Controlled Substances Act, DEA Immediate Suspension Orders and Orders to Show Cause, the Ruan intent standard for physicians, PAs, and NPs, and the civil exposure that runs alongside.

Read More